Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The eggs that this sandpiper is laying are waaaaaaayyyy over time
Hey Piper, the sand in your eyes makes you blind for the scientific reality!?
One has to be foolish to sell, a few days before some kind of announcement will blew the fuses!?
A clown named Flintstone deserves an orange suit like Martin Shkreli; maybe one can put them in the same room in order to exchange ideas about biostocks!?
Who's next? A. Fuckstein?
Aha, a shorter got his deserved punishment; wasn't it the one
who called AVXL a worthless company??
Life by the sword, die by the sword: https://thefly.com/landingPageNews.php?id=2281743&headline=AVXL;AVXLD-Anavex-Life-Sciences-looks-worthless-says-Shkreli
Finally a first example for those who short Anavex and/or distribute false rumors: https://www.cnbc.com/2018/03/06/prosecutors-want-martin-shkreli-in-prison-for-at-least-15-years.html
Hey Nidan 7500 and F1ash here's something to read top to bottom very very carefully and to chew on because it tastes delicious: https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2018022848&recNum=1&maxRec=13&office=&prevFilter=&sortOption=Pub+Date+Desc&queryString=FP%3A%28anavex%29&tab=PCTDescription
No it isn't a pub, but serious reality which will crunch the shorties: i really can feel already the burning fire and as a former investment banker, Christopher Missling knows exactly how to dismantle them.
Start the engines: A2-73 as a therapeutic for Insomnia, Anxiety and Agitation !!
A2-73 is a useful therapeutic in the treatment of humans suffering from insomnia, anxiety or agitation. Particular attention Is made to oral daily doses of from about 10mg to about 50mg, with particular reference to about 20 to 30 mg, but further including does of up to about 10Omg per day. Attention is also directed to A1 -41 and A19-144 as similarly useful therapeutics in insomnia, anxiety or agitation. Also presented is a method of moderating systolic blood pressure.
Anavex Germany GmbH - Am Klopferspitz 19 a, c/o BioM Biotech Cluster Development Gmbh, 82152 Martinsried - Germany
Company reg no: HRB231663 MÜNCHEN
Incorporated: 2017-02-27
Country: Germany
Court: DE/München
Name: ANAVEX AUSTRALIA PTY LTD
ACN: 601 048 702
ABN: 50601048702
Registered in: Queensland
Registration date: 04/08/2014
Next review date: 04/08/2018
Name start date: 04/08/2014
Status: Registered
Company type: Australian Proprietary Company
Class: Limited By Shares
Subclass: Proprietary Company
Well, well, well: Anavex, Anavex Australia, Anavex Germany and now Anavex Canada LTD: things are moving really forward and, thank God, will take the shorts by surprise...:))))
A short break, take a deep breath and up we go again;let's see what this brings in the afternoon!
The boat is loaded: let's start the cruise....:)))
Probably Missling is fully aware by waiting to spread the word till the roadshows are over!? It wouldn't be very nice for the heavy investors at Noble to tell them during the show that they've just missed a great opportunity to invest; wouldn't it be nicer to tell them:" These are the big things to happen in the near future and you can be part of the fireworks .....".
Something brewing....
Today and the coming days, but when? In the morning or afternoon?
And the winner is .....ANAVEX: https://www.bio.org/events/bio-ceo-investor-conference/buzz-of-bio
Closing green!?
No dog or pony show, he'll let the dogs out....
Maybe they haven chosen under pressure from Anavex the false door in the escape room?
Remarkable failure within ACORDA Therapeutics in their research on Parkinson's disease!
"On November 15, 2017, Acorda announced that it has stopped enrolling new patients in its Phase 3 trial of tozadenant due to 5 deaths which occurred in the group of patients who took tozadenant. Following this disclosure, Acorda stock has declined with more than 38%".
Conclusion: the world is waiting for ANAVEX!!!
In just one hour Missling presents http://www.abstractsonline.com/pp8/#!/4376/presentation/28724
"Suggested accessories are antacids, a hand held urinal, portapotty, and a clean supple of underwear"! Just buying shares is the contra-indication for this illness..:)))
Non deal road shows, November 6-8-9-10: https://noblecapitalmarkets.com/equity-research-home
Take it easy: countdown has started already!
Who let de dogs out? Come on Missling: yes we can !!!
STOP THE DECLINE !!!! ANAVEX A2-73 the continued ability of the medication to stop the decline in the exploratory secondary endpoints cognition (MMSE) and function (ADCS-ADL)
Somebody knows more!? Anavex, after hours,16:23:45 4.35 23,900 shares
http://www.nasdaq.com/symbol/avxl/after-hours?time=1
He knows how to be a brilliant financial strategist: before he came to Anavex Dr. Christopher Missling was a CFO and " his career experience also includes working as an investment banker in the healthcare practice at Deutsche Bank, serving pharmaceutical, biotech, and diagnostic companies, as well as serving as the head of healthcare investment banking at Brimberg & Co. in New York. Dr. Missling has an MS and PhD from the University of Munich in Chemistry and an MBA from Northwestern University Kellogg School of Management".
SHORTIES WATCH OUT !!! Neuroscience 2017, November 13:Missling himself will present a poster and said already in the abstract: Anavex 2-73 significantly improves an array of behavioral phenotypes in the Rett syndrome mouse model in a dose-related manner. Based on these data, Anavex Life Sciences will start a U.S. multicenter Phase 2 clinical trial of AV2-73 for the treatment of Rett syndrome with the support of Rettsyndrome Org".
Where are the hunters before the "kaboomy"-time on Monday: go ANAVEX!